Free Trial

EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down - Should You Sell?

EssilorLuxottica logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped down: EssilorLuxottica opened Monday at $103.20 after closing at $107.50 and last traded at $102.83 on volume 8,049, trading well below its 50‑day ($118.95) and 200‑day ($150.14) moving averages.
  • Analyst sentiment is positive: Kepler Capital Markets and HSBC recently upgraded the stock to Buy, and MarketBeat shows two Strong Buy, five Buy and one Hold for an overall average rating of "Buy".
  • Financials show tight liquidity but low leverage: The company has a current ratio of 0.99 and quick ratio of 0.70, with a low debt‑to‑equity ratio of 0.17.
  • MarketBeat previews top five stocks to own in June.

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $107.50, but opened at $103.20. EssilorLuxottica shares last traded at $102.83, with a volume of 8,049 shares.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ESLOY shares. Kepler Capital Markets raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research note on Thursday, January 15th. HSBC upgraded shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a report on Wednesday, January 14th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Buy".

Get Our Latest Analysis on ESLOY

EssilorLuxottica Stock Performance

The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The company's fifty day moving average price is $118.95 and its two-hundred day moving average price is $150.14.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EssilorLuxottica Right Now?

Before you consider EssilorLuxottica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.

While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines